Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062506861

Publication Date:

June 24, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Human Chorionic Gonadotrophin (HCG) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Human Chorionic Gonadotrophin (HCG) is a hormone produced during pregnancy. It is used as an indicator in pregnancy tests and can also be administered medically for various purposes.

This report is a detailed and comprehensive analysis for global Human Chorionic Gonadotrophin (HCG) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Chorionic Gonadotrophin (HCG)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Chorionic Gonadotrophin (HCG) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd., Shanghai Tianwei Biopharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Human Chorionic Gonadotrophin (HCG) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
u-hCG
r-hCG
麻豆原创 segment by Application
Drug
Pregnancy Test Paper
Other
麻豆原创 segment by players, this report covers
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Chorionic Gonadotrophin (HCG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Chorionic Gonadotrophin (HCG), with revenue, gross margin, and global market share of Human Chorionic Gonadotrophin (HCG) from 2020 to 2025.
Chapter 3, the Human Chorionic Gonadotrophin (HCG) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Chorionic Gonadotrophin (HCG) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Chorionic Gonadotrophin (HCG).
Chapter 13, to describe Human Chorionic Gonadotrophin (HCG) research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Human Chorionic Gonadotrophin (HCG) by Type
1.3.1 Overview: Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Human Chorionic Gonadotrophin (HCG) Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 u-hCG
1.3.4 r-hCG
1.4 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 by Application
1.4.1 Overview: Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug
1.4.3 Pregnancy Test Paper
1.4.4 Other
1.5 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size & Forecast
1.6 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast by Region
1.6.1 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
2.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Details
2.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Major Business
2.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
2.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
2.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Details
2.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Major Business
2.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
2.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
2.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Details
2.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Major Business
2.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
2.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Developments and Future Plans
2.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
2.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Details
2.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Major Business
2.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
2.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Human Chorionic Gonadotrophin (HCG) Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Human Chorionic Gonadotrophin (HCG) by Company Revenue
3.2.2 Top 3 Human Chorionic Gonadotrophin (HCG) Players 麻豆原创 Share in 2024
3.2.3 Top 6 Human Chorionic Gonadotrophin (HCG) Players 麻豆原创 Share in 2024
3.3 Human Chorionic Gonadotrophin (HCG) 麻豆原创: Overall Company Footprint Analysis
3.3.1 Human Chorionic Gonadotrophin (HCG) 麻豆原创: Region Footprint
3.3.2 Human Chorionic Gonadotrophin (HCG) 麻豆原创: Company Product Type Footprint
3.3.3 Human Chorionic Gonadotrophin (HCG) 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Human Chorionic Gonadotrophin (HCG) Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Human Chorionic Gonadotrophin (HCG) Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Human Chorionic Gonadotrophin (HCG) 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
6.2 North America Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Application (2020-2031)
6.3 North America Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Country
6.3.1 North America Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
6.3.2 United States Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
7.2 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
7.3 Europe Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Country
7.3.1 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
7.3.2 Germany Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Region
8.3.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Region (2020-2031)
8.3.2 China Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
9.2 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
9.3 South America Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Country
9.3.1 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
9.3.2 Brazil Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size by Country
10.3.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
10.3.2 Turkey Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Human Chorionic Gonadotrophin (HCG) 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Human Chorionic Gonadotrophin (HCG) 麻豆原创 Drivers
11.2 Human Chorionic Gonadotrophin (HCG) 麻豆原创 Restraints
11.3 Human Chorionic Gonadotrophin (HCG) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Human Chorionic Gonadotrophin (HCG) Industry Chain
12.2 Human Chorionic Gonadotrophin (HCG) Upstream Analysis
12.3 Human Chorionic Gonadotrophin (HCG) Midstream Analysis
12.4 Human Chorionic Gonadotrophin (HCG) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.